AMYRIS, INC. AMRS Cash Flow

Amyris, inc. (AMRS)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities
Net loss
-264,368	-242,767	-212,491	-227,382	-203,676	-230,235	-267,007	-226,415	-211,413	-155,982	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-147,502	-181,098	-218,052	-118,119	-78,103	-66,451	2,167	-195,276	-182,832	-186,236	-234,907	-139,071	-135,231	-143,452	-206,033	-222,051	-245,577	-241,260	-179,511	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Loss upon extinguishment of debt
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss upon conversion or extinguishment of debt
71,527	44,208	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of right-of-use assets under operating leases
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from change in fair value of debt
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
12,606	12,554	13,136	12,839	11,364	9,190	8,438	6,759	5,897	6,265	5,622	6,169	6,920	7,325	7,815	8,266	8,533	9,134	10,300	11,616	13,243	14,105	15,205	16,066	17,368	18,047	19,684	21,216	25,145	27,473	28,056	28,964	28,006	25,492	0	0	0
Amortization of right-of-use assets under operating leases
10,439	12,597	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
5,452	4,581	3,655	3,699	4,208	4,921	7,191	8,752	10,204	11,358	10,937	11,204	11,220	11,374	11,550	11,800	12,299	12,920	13,566	14,270	14,659	14,969	15,714	15,687	16,049	16,639	16,143	15,554	15,273	14,570	14,035	13,753	12,659	11,077	0	0	0
Loss from change in fair value of debt
0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of premium on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	630	0	0	0
Accretion of debt discount
8,329	11,665	14,059	15,633	16,441	16,602	17,375	15,831	15,555	15,239	15,363	14,667	15,924	14,445	13,116	22,830	58,331	58,559	57,820	49,362	11,604	9,981	8,342	6,385	4,787	3,683	2,657	1,899	1,333	838	0	0	0	-	-	-	-
Loss in equity-method investee
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of property, plant and equipment
-237	-200	-120	5	93	-941	-1,048	-1,245	-1,232	-142	-12	200	179	161	103	69	-91	-154	-232	-307	-256	-263	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Write-down of property, plant and equipment
920	1,354	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on foreign currency exchange rates
23	22	1,452	2,228	2,574	2,223	2,157	1,324	692	1,230	1,310	463	855	-557	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on purchase commitments and write-off of property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,187	17,625	9,202	45,854	38,090	36,652	36,652	0	0	0	0
(Gain) loss from change in fair value of derivative liabilities
8,098	2,777	27,847	3,448	25,438	-30,880	-119,581	-123,334	-109,548	-48,852	9,094	36,858	22,016	41,355	68,381	47,477	55,377	16,287	85,722	101,412	69,326	144,138	-41,873	-31,297	-28,365	-84,726	7,423	3,698	2,803	1,764	0	0	0	-	-	-	-
Loss upon extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-3,834	-4,146	3,977	-1,790	-1,357	-1,141	-5,984	0	-1,082	-10,512	-30,426	-30,426	-29,344	-19,914	0	0	0	-	-	-	-	-	-	-	-
Inventory write-down to net realizable value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Loss on disposal of property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-243	-151	-438	-370	-260	-233	-54	-52	0	0	0
Loss on purchase commitments and impairment of property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,769	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on change in fair value of equity investment
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-cash expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,741	-414	0	129	113	115	115	-227	-211	-264	-187	-46	-159	-227	-327	-127	-40	0	0	0
Loss from investments in affiliates
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in assets and liabilities:
Accounts receivable
13,075	2,818	-1,740	5,655	-12,422	-7,448	6,474	5,182	24,961	19,647	18,549	12,285	2,087	8,959	2,247	1,935	1,618	-4,271	-7,032	-1,383	1,907	1,217	8,843	-2,870	-1,299	4,365	-1,363	4,196	-41	-2,837	-655	-1,998	53	1,975	0	0	0
Contract assets
9,355	8,485	2,567	-13,171	93	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable, unbilled
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable, unbilled - related party
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Related party accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	753	-	-65	-23	58	4	-459	682	-2,520	484	0	0	0	-	-	-	-	-	-	-	-
Inventories
23,577	17,989	10,135	7,413	3,640	4,416	3,890	4,848	1,839	3,126	-1,692	-4,185	-949	-5,686	-5,032	-3,028	-6,113	-4,470	-4,973	-2,441	2,463	4,481	9,170	10,332	4,977	5,612	283	-3,939	-2,558	-2,919	92	2,358	320	5,327	0	0	0
Deferred cost of products sold - related party
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred cost of products sold - related party
5,860	13,175	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
0	-	-	-	0	-	-	-	11,270	18,730	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	3,385	-	3,791	4,672	2,121	2,907	3,600	4,374	2,743	2,743	893	-15,505	-11,520	-11,239	5,461	20,231	17,222	17,250	0	0	0
Accounts payable
22,232	23,748	14,348	13,048	13,545	11,603	-2,462	10,278	4,894	5,452	5,255	3,513	7,702	6,442	1,377	2,597	3,181	4,373	4,996	-2,122	-1,881	-3,209	-6,387	1,155	-1,956	-2,636	2,237	-4,649	-11,020	-11,811	-6,545	521	7,043	15,648	0	0	0
Accrued and other liabilities
16,745	18,981	22,423	22,840	25,826	8,461	21,821	-786	-758	13,877	-1,085	11,730	12,510	11,919	12,364	11,803	8,528	10,386	13,512	14,153	12,344	6,830	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities
-14,132	-17,125	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued and other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,358	-40,153	-26,212	-35,754	0	0	0	-	-	-	-
Accrued and other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	714	-2,412	-4,293	-10,893	-89	1,348	2,523	4,772	4,760	949	465	1,289	1,634	6,423	7,172	7,935	-1,648	-353	5,527	5,945	5,542	0	0	0
Contract liabilities
-5,135	-6,900	756	5,811	-998	3,158	-9,440	-4,544	-1,133	-7,241	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-166,328	-156,933	-133,386	-113,135	-121,177	-109,366	-87,974	-95,488	-100,955	-101,179	0	0	0	-	-	-	-	-	-	0	0	-	-100,542	-96,418	-91,522	-105,859	-100,603	-104,530	-113,306	-150,872	-146,421	-136,262	-134,781	-92,496	0	0	0
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-619	-	-391	-215	-70	60	153	247	122	-233	-674	-1,116	-1,320	-1,277	-1,235	-1,192	-1,149	-1,053	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investing activities
Change in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-257	-253	-240	0	0	0	-	-	-	-	736	2	3	956	955	0	0	0	-	-	-	-
Acquisition of cash in noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	344	0	0	0
Deposits on property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26	31,377	13,067	14,754	15,107	0	0	0
Change in short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property, plant and equipment
11,074	13,080	15,123	14,216	13,934	12,472	10,287	8,355	5,539	4,412	690	786	1,108	922	1,741	1,955	2,554	3,367	10,965	8,880	7,396	5,004	-5,802	-6,440	-7,277	-8,087	-12,389	-17,266	-38,022	-56,832	-77,845	-94,763	-88,928	-81,917	0	0	0
Maturities of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	6,187	3,594	3,711	3,055	2,321	2,453	1,572	1,272	1,409	1,051	1,979	2,311	1,281	1,209	334	0	0	0	8,000	50,000	105,000	0	0	0
Sale of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,503	39,729	84,555	84,555	68,106	0	0	0
Purchase of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	5,559	3,843	3,950	3,259	2,759	2,414	1,663	1,367	1,371	1,921	1,915	2,169	2,795	1,914	1,858	1,603	8,334	20,510	59,205	74,027	67,556	0	0	0
Net cash used in investing activities
-11,074	-13,080	-15,123	-14,059	-13,934	-12,472	42,834	47,693	50,252	51,708	0	0	0	-	-	-	-	-	-	0	0	-	-10,696	-9,186	-7,870	-10,337	-12,506	-16,677	-39,704	-49,644	-61,434	-82,530	-46,877	5,853	0	0	0
Financing activities
Proceeds from issuance of debt, net of issuance costs
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of common stock rights warrant - related party
54,500	39,500	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock in private placement, net of issuance costs - related party
29,221	14,221	40,915	14,220	1,323	1,415	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	19,980	42,173	42,080	46,011	84,682	62,490	62,582	58,606	0	0	0	0
Proceeds from exercises of warrants - related party
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock in private placement, net of issuance costs
199,175	189,175	0	0	0	-	-	-	-	18,925	64,601	66,416	65,411	63,911	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercises of warrants
3,332	1	-2,776	43,219	57,635	57,767	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of debt, net of issuance costs
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercises of common stock options
14	27	-28	53	220	288	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on financing leases
-	-	-	-	-	981	0	0	0	-	602	1,837	2,046	1,579	1,112	803	524	729	812	962	1,154	1,045	1,078	1,014	998	1,366	1,872	2,518	3,260	3,727	3,696	3,524	3,243	2,835	0	0	0
Payment of minimum employee taxes withheld upon net share settlement of restricted stock units
1,102	1,103	663	431	203	260	522	460	429	385	138	162	227	253	222	221	381	333	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on financing leases
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from debt issued, net of discounts and issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83,171	90,997	91,061	37,901	10,535	5,989	30,893	56,417	78,904	105,959	80,960	55,384	37,957	0	0	0
Proceeds from debt issued to related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	29,699	25,000	25,000	20,000	10,850	10,850	21,700	35,712	49,862	84,862	94,012	90,000	65,000	0	0	0	-	-	-	-	-	-	-	-
Principal payments on debt
118,797	112,393	63,373	56,776	35,711	41,668	52,762	50,165	38,910	37,500	29,025	27,558	14,154	9,759	37,012	40,796	38,381	40,819	12,355	8,733	5,854	5,733	0	0	0	-	3,075	45,077	52,920	52,633	53,108	10,816	2,238	5,018	0	0	0
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock in August 2017 offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,488	3,136	1,038	2,124	1,134	940	1,159	1,411	1,479	4,154	4,648	8,416	8,445	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of offering costs in initial public offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-497	0	0	0
Net cash provided by (used in) financing activities
174,795	124,910	130,539	113,238	114,429	107,957	45,280	54,698	75,443	77,864	0	0	0	-	-	-	-	-	-	0	0	-	173,890	183,301	122,916	91,181	73,567	65,949	77,071	138,117	148,799	136,849	119,922	41,052	0	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-163	-252	-224	-506	-79	-77	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-316	-134	32	559	-1,203	-1,961	-1,886	-1,889	-1,203	-1,191	-372	1,024	1,291	925	-303	-4,228	-2,712	-2,713	-3,162	-623	-1,766	0	0	0
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	15,158	-10,321	-10,056	-35,955	-30,055	-56,314	-77,950	-4,017	35,179	61,461	77,325	24,548	-23,724	-38,617	-55,561	-80,167	-65,111	-61,769	-85,105	-62,359	-47,357	0	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash, cash equivalents and restricted cash
-2,770	-45,355	-18,194	-14,462	-20,761	-13,958	361	7,004	24,941	28,579	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of cash flow information:
Cash paid for interest
20,833	20,780	14,131	17,876	19,808	18,524	19,517	15,647	11,491	11,539	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	8,896	-	9,265	10,020	7,462	6,910	0	0	0	-	-	0	0	-	-	-	-	1,412	0	0	0
Cash paid for income taxes, net of refunds
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Supplemental disclosures of non-cash investing and financing activities:
Interest capitalized to debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued interest added to debt principal
8,371	7,292	2,621	2,218	2,901	3,664	3,100	2,965	2,912	2,816	0	0	0	-	-	-	-	6,354	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of property, plant and equipment under accounts payable, accrued liabilities and notes payable
0	-	0	0	0	-	0	0	0	-	1,278	458	90	-1,252	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of right-of-use assets under operating leases
2,800	3,600	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right of Use Assets Under Operating Leases Recorded Upon Adoption of ASC842
0	29,713	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cumulative effect of change in accounting principle
-41,043	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Derecognition of derivative liabilities upon exercise of warrants
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants recorded as debt discount in connection with debt issuances
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants and embedded features recorded as debt discount in connection with debt issuances - related party
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants recorded as debt discount in connection with debt modification
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions of property, plant and equipment under accounts payable, accrued liabilities and notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	-	-	0	-	-	-	-	3,177	0	0	0
Financing of equipment
-	-	-	-	-	-	-	-	-	-	1,813	998	2,216	2,136	1,276	1,586	633	613	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for settlement of debt
-	-	-	-	-	-	-	-	-	10,708	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued issuance cost of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Receivable of proceeds for options exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0	-	-	-	-	-	-	0	0
Purchase of property, plant and equipment via deposit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash investment in joint venture
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cancellation of debt and accrued interest on disposal of interest in affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	4,252	4,252	4,252	4,252	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in unrealized gain (loss) on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Change in unrealized gain (loss) on foreign currency
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Issuance of common stock upon exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,554	0	0	0
Conversion of other liability to related party debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Issuance of common stock upon conversion of convertible notes
0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities recorded upon adoption of ASC 842
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities recorded upon adoption of ASC 842
0	33,552	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-of-use assets under operating leases recorded upon adoption of ASC 842
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash Or Part Noncash, Exercise Of Common Stock Warrants For Debt Principal And Accrued Interest Reduction
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair Value Of Embedded Features In Connection With Private Placement
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants recorded as debt discount in connection with debt issuances
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants recorded as debt discount in connection with debt issuances - related party
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants recorded as debt discount in connection with debt modification
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing of equipment under financing leases
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of noncontrolling interest in Glycotech via debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing of insurance premium under note payable
-	-	-	-	-	-	-	-	-	467	383	383	182	-123	-26	-101	-83	53	291	323	184	166	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Accrued offering cost of common stock in private placement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Accrued issuance cost of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Transfer of long term deposits to property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	0	0	0